Vai al contenuto
AusGrant
UE Aperto EU-FUNDING-PORTAL-HORIZON-HLTH-2023-CARE-08-01

European Partnership on Personalised Medicine

European Commission (EC) · Competitivo · Horizon Europe

In sintesi

European Partnership on Personalised Medicine è un contributo a livello UE di tipo « Competitivo » erogato da European Commission. Finanziamento: Fino a €37M. Candidati ammissibili: Open to eligible organisations in EU Member States and Horizon Europe associated countries; consortium requirements vary by topic - see the official call conditions. La scadenza per la candidatura è il 20 gennaio 2027. Candidati tramite l'annuncio ufficiale su ec.europa.eu.

Importo
Fino a €37M
Scadenza
20 gen 2027
Tipo
Competitivo
Stato
Aperto

Il programma

With this JTC, EP PerMed will fund research projects in human health on Cell and Gene Therapies (CGT) for PM approaches. Proposals must focus on the development and validation of an innovative and novel CGT for PM.At least one of the following approaches must be employed:Somatic cell therapeutics;Gene therapeutics;Combined cell- and gene therapeutics;Novel biological products.For the entire scope, please consult the Call Text: https://www.eppermed.eu/funding-projects/calls/jtc2027/.

Chi può fare domanda

Open to eligible organisations in EU Member States and Horizon Europe associated countries; consortium requirements vary by topic - see the official call conditions.

Come fare domanda

Apply through the EU Funding & Tenders portal; submission is electronic via the portal's Submission Service before the topic deadline.

Fai domanda sulla fonte ufficiale